Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

NCT03927274 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Funding unavailable

Conditions

Glioma of Brain

Interventions

DRUG: Topotecan

Sponsor

H. Lee Moffitt Cancer Center and Research Institute